Oltipraz clinical trials
How each study uses oltipraz is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Oltipraz
- 4
Studies by the year they started
4 studies that test it; most in 2000 (1)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2011 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
PharmaKing (2) · Northwestern University (1) · HK inno.N Corporation (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses oltipraz is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver CirrhosisCompletedPhase 3PharmaKingNCT04142749Written as Oltipraz
- Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver DiseaseCompletedPhase 2PharmaKingNCT01373554Written as Oltipraz
- Oltipraz in the Prevention of Lung Cancer in People Who SmokeCompletedPhase 1Northwestern UniversityNCT00006457Written as oltipraz
- Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and CirrhosisCompletedPhase 2HK inno.N CorporationNCT00956098Written as oltipraz
Codes
What other systems call oltipraz · ClinicalTrials.gg INT002830
- MeSH (NLM) C026209oltiprazConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6N510JUL1YOLTIPRAZConfirmed FDA, NLM, Wikidata
- Wikidata Q7088765oltiprazConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1177OltiprazOne source FDA
- DrugBank DB12539One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C026209 | oltipraz | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6N510JUL1Y | OLTIPRAZ | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7088765 | oltipraz | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1177 | Oltipraz | One source FDA |
| DrugBank | DB12539 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.